1.1746
price up icon3.54%   0.0446
 
loading

Hoth Therapeutics Inc (HOTH) 最新ニュース

pulisher
Jun 18, 2025

Hoth Therapeutics reports positive preclinical safety data for HT-KIT By Investing.com - Investing.com South Africa

Jun 18, 2025
pulisher
Jun 18, 2025

Hoth Therapeutics Regains Nasdaq Compliance - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Hoth Therapeutics regains Nasdaq compliance after meeting minimum bid - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Hoth Therapeutics Just Cleared Critical Nasdaq Hurdle: What This Means for Its $1B+ Biotech Pipeline - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

Hoth Therapeutics Reports Positive Preclinical Safety Data for Cancer Fighting HT-KIT Dose-Dependent Liver Activity with No Observed Toxicity Supports Ind Pathway - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Hoth Therapeutics (HOTH) Reports Promising Preclinical Outcomes for Cancer Drug | HOTH Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Cancer Drug Breakthrough: Hoth's HT-KIT Achieves Perfect Safety Profile Ahead of Clinical Trials - Stock Titan

Jun 18, 2025
pulisher
Jun 16, 2025

Market Momentum Report: Hoth Therapeutics Inc (HOTH)’s Negative Close at 1.30 - DWinneX

Jun 16, 2025
pulisher
Jun 16, 2025

Hoth Therapeutics Joins 20,000 Biotech Leaders at World's Largest Industry Convention - Stock Titan

Jun 16, 2025
pulisher
Jun 13, 2025

Hoth Therapeutics (HOTH) Secures Patent for HT-KIT Platform in J - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Hoth Therapeutics (NASDAQ:HOTH) Receives “Buy” Rating from D. Boral Capital - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Hoth Therapeutics secures Japanese patent for mast cell disease treatment By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Hoth Therapeutics secures Japanese patent for mast cell disease treatment - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Hoth Therapeutics Secures 15-Year Japanese Patent Protection for Revolutionary Mast Cell Disease Platform - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

Hoth Therapeutics (HOTH) Receives 'Buy' Rating from D. Boral Capital | HOTH Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Hoth Therapeutics plans expanded access program for cancer skin toxicity drug - Investing.com India

Jun 12, 2025
pulisher
Jun 11, 2025

Hoth Therapeutics plans expanded access program for cancer skin toxicity drug By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Hoth Therapeutics, Inc. Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Hoth Therapeutics Launches Expanded Access Initiative For HT-001 - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

HOTH Seeks Expanded Access for HT-001 to Address Skin Toxicities | HOTH Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Hoth Expands Access to Cancer Skin Toxicity Treatment HT-001 in Phase 2a Success | HOTH Stock News - Stock Titan

Jun 11, 2025
pulisher
Jun 05, 2025

Hoth Therapeutics advances with HT-001 oncology skin care treatment By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Hoth Therapeutics advances with HT-001 oncology skin care treatment - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough Combating Cancer Treatment Skin Toxicities - PR Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

First-Ever Treatment for EGFR Cancer Therapy Skin Toxicities: Experts Review Game-Changing Clinical Data - Stock Titan

Jun 05, 2025
pulisher
Jun 04, 2025

Hoth Therapeutics, Inc. (NASDAQ:HOTH) Sees Large Increase in Short Interest - Defense World

Jun 04, 2025
pulisher
May 31, 2025

Hoth Therapeutics (NASDAQ:HOTH) Stock Rating Upgraded by Wall Street Zen - Defense World

May 31, 2025
pulisher
May 28, 2025

Hoth Therapeutics (NASDAQ:HOTH) Shares Up 0.7% – What’s Next? - Defense World

May 28, 2025
pulisher
May 16, 2025

Hoth Therapeutics Faces Nasdaq Compliance Challenge - TipRanks

May 16, 2025
pulisher
May 13, 2025

Hoth Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 12, 2025

HOTH THERAPEUTICS Earnings Results: $HOTH Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Hoth Therapeutics reports promising HT-KIT preclinical results By Investing.com - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

Hoth Therapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Hoth Therapeutics Reports Positive Preclinical Results for HT-KIT, a Precision Antisense Therapy Targeting Rare and Aggressive KIT-Driven Cancers - PR Newswire

May 12, 2025
pulisher
May 12, 2025

Hoth Therapeutics reports promising HT-KIT preclinical results - Investing.com Australia

May 12, 2025
pulisher
May 11, 2025

Hoth Therapeutics (HOTH) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 05, 2025

Geode Capital Management LLC Purchases 13,038 Shares of Hoth Therapeutics, Inc. (NASDAQ:HOTH) - Defense World

May 05, 2025
pulisher
May 02, 2025

Hoth Therapeutics confirms patent application fee payment By Investing.com - Investing.com Nigeria

May 02, 2025
pulisher
May 02, 2025

Hoth Therapeutics confirms patent application fee payment - Investing.com

May 02, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 27, 2025

Treatment With HT-KIT Shows Early Preclinical Activity in GIST Models - Curetoday

Apr 27, 2025
pulisher
Apr 21, 2025

Quarterly Snapshot: Quick and Current Ratios for Hoth Therapeutics Inc (HOTH) - DWinneX

Apr 21, 2025
pulisher
Apr 18, 2025

Hoth Therapeutics’ (HOTH) “Buy” Rating Reiterated at D. Boral Capital - Defense World

Apr 18, 2025
pulisher
Apr 18, 2025

Hoth secures Japan patent for RNA cancer therapy targeting KIT gene - Investing.com Canada

Apr 18, 2025
pulisher
Apr 17, 2025

Hoth secures Japan patent for RNA cancer therapy targeting KIT gene By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 17, 2025

Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT GeneExpands Global IP in Precision Oncology Platform - PR Newswire

Apr 17, 2025
pulisher
Apr 16, 2025

Hoth Therapeutics (HOTH) Reports Promising Phase 2a Results for Pruritus Treatment | HOTH Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Hoth Therapeutics reports progress in pruritus treatment trial By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

Hoth Therapeutics Announces Positive Initial Data In Phase 2A Clinical Trial - marketscreener.com

Apr 15, 2025
$20.61
price up icon 0.56%
$35.98
price up icon 0.29%
$21.10
price up icon 2.40%
$100.57
price up icon 0.94%
$106.66
price up icon 0.07%
biotechnology ONC
$242.50
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):